These results suggest that the prognosis of breast cancer patients is significantly different depending on the existence of the mutant TP53 gene and that gene pairs are more prognostic of survival than single genes in patients with a wild-type TP53 gene. This evidence concerns the gene TP53 and breast carcinoma.